Cerevel Therapeutics
CERE
#1945
Rank
โ‚ฌ7.90 B
Marketcap
43,38ย โ‚ฌ
Share price
0.00%
Change (1 day)
121.13%
Change (1 year)

Revenue for Cerevel Therapeutics (CERE)

Revenue in 2024 (TTM): N/A

In 2023 the company made a revenue of N/A a decrease over the revenue in the year 2022 that were of N/A. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Cerevel Therapeutics from 2020 to 2024

Annual revenue

Year Revenue Change
2024 (TTM) N/A
2023 N/A
2022 N/A
2021 N/A
2020 N/A

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
โ‚ฌ83.94 BN/A๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ41.65 BN/A๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ11.76 BN/A๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ9.54 BN/A๐Ÿ‡บ๐Ÿ‡ธ USA